IMMUNOLOGICAL PARAMETERS 2 YEARS AFTER HIGH-TITER MEASLES IMMUNIZATION IN PERUVIAN CHILDREN

被引:48
作者
LEON, ME
WARD, B
KANASHIRO, R
HERNANDEZ, H
BERRY, S
VAISBERG, A
ESCAMILLA, J
CAMPOS, M
BELLOMO, S
AZABACHE, V
HALSEY, NA
机构
[1] LOUISIANA STATE UNIV, DEPT PEDIAT, NEW ORLEANS, LA USA
[2] MONTREAL GEN HOSP, MCGILL CTR STUDY HOST RESISTANCE, MONTREAL H3G 1A4, QUEBEC, CANADA
[3] UNIV PERUANA CAYETANO HEREDIA, INST NACL SALUD, ESCUELA MED, NAVAL MARINE DETACHMENT RES UNIT, LIMA, PERU
[4] UNIV PERUANA CAYETANO HEREDIA, DEPT MICROBIOL & MATEMAT, NAVAL MARINE DETACHMENT UNIT, LIMA, PERU
关键词
D O I
10.1093/infdis/168.5.1097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunization with high-titer measles vaccines has been associated with excess mortality in children 2-4 years after vaccination. In this study, immunologic parameters in 64 Peruvian children who had been immunized an average of 27 months earlier with high-titer vaccines were compared with parameters in 76 recipients of low-titer vaccines. Delayed-type hypersensitivity, lymphocyte phenotype distributions by flow cytometry, and lymphoproliferation after phytohemagglutinin (PHA) stimulation were assessed. High-titer recipients had smaller indurations to tetanus, diphtheria, and Proteus (P < .05) antigens, decreased PHA stimulation (P = .04), and a lower percentage of CD4+ lymphocytes (P = .04) than low-titer recipients. After adjustment for sex, concurrent illnesses, and other variables in regression analyses, high-titer recipients had a lower percentage of CD4+ lymphocytes (P = .025) and decreased lymphocyte proliferation to PHA (P = .058). These results may provide a clue to the pathogenesis of delayed excess mortality after high-titer measles vaccination in some developing countries.
引用
收藏
页码:1097 / 1104
页数:8
相关论文
共 68 条
  • [1] AABY P, 1991, LANCET, V338, P1518, DOI 10.1016/0140-6736(91)92330-5
  • [2] DELAYED EXCESS MORTALITY AFTER EXPOSURE TO MEASLES DURING THE 1ST 6 MONTHS OF LIFE
    AABY, P
    BUKH, J
    KRONBORG, D
    LISSE, IM
    DASILVA, MC
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (02) : 211 - 219
  • [3] LONG-TERM SURVIVAL AFTER EDMONSTON-ZAGREB MEASLES VACCINATION IN GUINEA-BISSAU - INCREASED FEMALE MORTALITY-RATE
    AABY, P
    KNUDSEN, K
    WHITTLE, H
    LISSE, IM
    THAARUP, J
    POULSEN, A
    SODEMANN, M
    JAKOBSEN, M
    BRINK, L
    GANSTED, U
    PERMIN, A
    JENSEN, TG
    ANDERSEN, H
    DASILVA, MC
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (06) : 904 - 908
  • [4] MEASLES VACCINATION AND REDUCTION IN CHILD-MORTALITY - A COMMUNITY STUDY FROM GUINEA-BISSAU
    AABY, P
    BUKH, J
    LISSE, IM
    SMITS, AJ
    [J]. JOURNAL OF INFECTION, 1984, 8 (01) : 13 - 21
  • [5] AAY P, 1988, LANCET, V2, P809
  • [6] ABO T, 1981, J IMMUNOL, V126, P1360
  • [7] [Anonymous], 1990, WKLY EPIDEMIOL REC, V65, P5
  • [8] [Anonymous], 1992, WKLY EPIDEMIOL REC, V67, P357
  • [9] ARNEBORN P, 1983, CLIN EXP IMMUNOL, V51, P165
  • [10] LYMPHOCYTE-T SUB-POPULATIONS IN RELATION TO IMMUNOSUPPRESSION IN MEASLES AND VARICELLA
    ARNEBORN, P
    BIBERFELD, G
    [J]. INFECTION AND IMMUNITY, 1983, 39 (01) : 29 - 37